FitLife Brands Inc (FTLF) — Titan Protect Analysis

FTLF

FitLife Brands Inc

Consumer Defensive · ·

$9.87

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$92M

Total market value of the company

Trailing P/E

16.33

Reasonably valued

Forward P/E

5.38

Based on estimated future earnings — lower means cheaper

Rev Growth

+58.9%

Year-over-year revenue change

Profit Margin

6.6%

How much profit the company keeps from each dollar of revenue

ROE

14.3%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$17.50

+77% from current price — median analyst estimate

Recommendation

NONE

Consensus view from 2 analysts covering this stock

About FitLife Brands Inc

FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; general wellness products with an emphasis on natural, vegan, and organic ingredients; male health and weight loss products; energy products; general health supplements; and natural skincare and beauty products; supplements focused on targeted nutrition; supplements for

https://www.fitlifebrands.com

Country: United States Employees: 81 Industry: Packaged Foods

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

-0.174

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0374

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.341

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-19.5%

Historical annualised return based on price data

Max Drawdown

-57.2%

Largest peak-to-trough decline — the worst it has been

HMM State

CRISIS

Elevated risk detected — extreme caution warranted

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

-0.01

Very low correlation to market moves

52W High

$20.98

53% below the year high

52W Low

$8.67

14% above the year low

Avg Volume

30,703

Average daily shares traded — higher means easier to buy and sell

Short Ratio

5.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$0.60

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

93.05

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

38.7%

Revenue left after cost of goods — higher means pricing power

Operating Margin

12.1%

Profit from core operations before interest and tax

Free Cash Flow

$-1,327,875

Negative — the business is spending more than it generates

Revenue (TTM)

$91M

Total revenue over the last 12 months

Net Income

$6M

Profitable — the bottom line is positive

Analyst Coverage

Analysts

Target High

$18.00

Target Median

$17.50

Target Low

$17.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go